<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39201064</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>01</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2077-0383</ISSN><JournalIssue CitedMedium="Print"><Volume>13</Volume><Issue>16</Issue><PubDate><Year>2024</Year><Month>Aug</Month><Day>21</Day></PubDate></JournalIssue><Title>Journal of clinical medicine</Title><ISOAbbreviation>J Clin Med</ISOAbbreviation></Journal><ArticleTitle>Coxsackievirus Group B Infections during Pregnancy: An Updated Literature Review.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">4922</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/jcm13164922</ELocationID><Abstract><AbstractText>Coxsackievirus group B (CVB), a member of the <i>Picornaviridae</i> family and enterovirus genus, poses risks during pregnancy due to its potential to cause severe fetal and neonatal infections. Transmission primarily occurs through fecal-oral routes, with infections peaking mostly in warmer months. Vertical transmission to the fetus can lead to conditions such as myocarditis, encephalitis, and systemic neonatal disease, presenting clinically as severe myocardial syndromes and neurological deficits. Diagnostic challenges include detecting asymptomatic maternal infections and conducting in utero assessments using advanced techniques like RT-PCR from amniotic fluid samples. Morbidity and mortality associated with congenital CVB infections are notable, linked to preterm delivery, fetal growth restriction, and potential long-term health impacts such as type 1 diabetes mellitus and structural cardiac anomalies. Current treatments are limited to supportive care, with emerging therapies showing promise but requiring further study for efficacy in utero. Preventive measures focus on infection control and hygiene to mitigate transmission risks, which are crucial especially during pregnancy. Future research should aim to fill knowledge gaps in epidemiology, improve diagnostic capabilities, and develop targeted interventions to enhance maternal and fetal outcomes.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Longo</LastName><ForeName>Carolina</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Obstetrics, Paulista School of Medicine, Federal University of São Paulo (EPM-UNIFESP), São Paulo 04023-062, SP, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saito</LastName><ForeName>Mauricio</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>CONCEPTUS-Fetal Medicine Center, São Paulo 04001-084, SP, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Castro</LastName><ForeName>Pedro Teixeira</ForeName><Initials>PT</Initials><AffiliationInfo><Affiliation>Department of Fetal Medicine, Biodesign Laboratory DASA/PUC, Rio de Janeiro 22451-900, RJ, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Traina</LastName><ForeName>Evelyn</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Obstetrics, Paulista School of Medicine, Federal University of São Paulo (EPM-UNIFESP), São Paulo 04023-062, SP, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Werner</LastName><ForeName>Heron</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0002-8620-7293</Identifier><AffiliationInfo><Affiliation>Department of Fetal Medicine, Biodesign Laboratory DASA/PUC, Rio de Janeiro 22451-900, RJ, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Elito Júnior</LastName><ForeName>Julio</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Obstetrics, Paulista School of Medicine, Federal University of São Paulo (EPM-UNIFESP), São Paulo 04023-062, SP, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Araujo Júnior</LastName><ForeName>Edward</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0002-6145-2532</Identifier><AffiliationInfo><Affiliation>Department of Obstetrics, Paulista School of Medicine, Federal University of São Paulo (EPM-UNIFESP), São Paulo 04023-062, SP, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Discipline of Woman Health, Municipal University of São Caetano do Sul (USCS), São Caetano do Sul 09521-160, SP, Brazil.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>08</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>J Clin Med</MedlineTA><NlmUniqueID>101606588</NlmUniqueID><ISSNLinking>2077-0383</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">coxsackievirus group B</Keyword><Keyword MajorTopicYN="N">fetal malformation</Keyword><Keyword MajorTopicYN="N">maternal infection</Keyword><Keyword MajorTopicYN="N">perinatal outcomes</Keyword><Keyword MajorTopicYN="N">vertical transmission</Keyword></KeywordList><CoiStatement>The authors report no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>6</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>7</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>8</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>8</Month><Day>31</Day><Hour>9</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>8</Month><Day>31</Day><Hour>9</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>8</Month><Day>29</Day><Hour>1</Hour><Minute>11</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>8</Month><Day>21</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39201064</ArticleId><ArticleId IdType="pmc">PMC11355224</ArticleId><ArticleId IdType="doi">10.3390/jcm13164922</ArticleId><ArticleId IdType="pii">jcm13164922</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Kühl U., Pauschinger M., Noutsias M., Seeberg B., Bock T., Lassner D., Poller W., Kandolf R., Schultheiss H.-P. High prevalence of viral genomes and multiple viral infections in the myocardium of adults with “idiopathic” left ventricular dysfunction. Circulation. 2005;111:887–893. doi: 10.1161/01.cir.0000155616.07901.35.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.cir.0000155616.07901.35</ArticleId><ArticleId IdType="pubmed">15699250</ArticleId></ArticleIdList></Reference><Reference><Citation>Romero J.R. Enteroviruses. In: Richman D.D., Whitley R.J., Hayden F.G., editors. Clinical Virology, 3rd ed. American Society for Microbiology Press; Washington, DC, USA: 2009. pp. 1031–1062.</Citation></Reference><Reference><Citation>Adams M.J., Lefkowitz E.J., Harrach B., Harrison R.L., Knowles N.J., Kropinski A.M., Krupovic M., Kuhn J.H., Mushegian A.R., Nibert M., et al. Ratification vote on taxonomic proposals to the International Committee on Taxonomy of Viruses (2016) Arch. Virol. 2016;161:2921–2949. doi: 10.1007/s00705-016-2977-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00705-016-2977-6</ArticleId><ArticleId IdType="pmc">PMC7086986</ArticleId><ArticleId IdType="pubmed">27424026</ArticleId></ArticleIdList></Reference><Reference><Citation>Konstantinidou A., Anninos H., Spanakis N., Kotsiakis X., Syridou G., Tsakris A., Patsouris E. Transplacental infection of coxsackievirus B3 pathological findings in the fetus. J. Med. Virol. 2007;79:754–757. doi: 10.1002/jmv.20887.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.20887</ArticleId><ArticleId IdType="pubmed">17457913</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim B., Ju E., Lao D.H., Yun S., Lee Y., Kim D., Jeon E. Development of a enterovirus diagnostic assay system for diagnosis of viral myocarditis in humans. Microbiol. Immunol. 2013;57:281–287. doi: 10.1111/1348-0421.12028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1348-0421.12028</ArticleId><ArticleId IdType="pubmed">23586632</ArticleId></ArticleIdList></Reference><Reference><Citation>Muehlenbachs A., Bhatnagar J., Zaki S.R. Tissue tropism, pathology and pathogenesis of enterovirus infection. J. Pathol. 2014;235:217–228. doi: 10.1002/path.4438.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/path.4438</ArticleId><ArticleId IdType="pubmed">25211036</ArticleId></ArticleIdList></Reference><Reference><Citation>Increased Detections and Severe Neonatal Disease Associated with Coxsackievirus B1 Infection—United States.  [(accessed on 14 July 2024)];2007  Available online:  https://www.cdc.gov/mmwr/preview/mmwrhtml/mm5720a4.htm.</Citation><ArticleIdList><ArticleId IdType="pubmed">18496504</ArticleId></ArticleIdList></Reference><Reference><Citation>Wikswo M.E., Khetsuriani N., Fowlkes A.L., Zheng X., Peñaranda S., Verma N., Shulman S.T., Sircar K., Robinson C.C., Schmidt T., et al. Increased activity of Coxsackievirus B1 strains associated with severe disease among young infants in the United States, 2007–2008. Clin. Infect. Dis. 2009;49:e44–e51. doi: 10.1086/605090.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/605090</ArticleId><ArticleId IdType="pubmed">19622041</ArticleId></ArticleIdList></Reference><Reference><Citation>Modlin J.F. Perinatal Echovirus and Croup B Coxsackievirus infections. Clin. Perinatol. 1988;15:233–246. doi: 10.1016/s0095-5108(18)30709-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0095-5108(18)30709-7</ArticleId><ArticleId IdType="pubmed">2837356</ArticleId></ArticleIdList></Reference><Reference><Citation>Bopegamage S., Precechtelova J., Marosova L., Stipalova D., Sojka M., Borsanyiova M., Gomolcak P., Berakova K., Galama J.M. Outcome of challenge with cox-sackievirus B4 in young mice after maternal infection with the same virus during gestation. FEMS Immunol. Med. Microbiol. 2012;64:184–190.</Citation><ArticleIdList><ArticleId IdType="pubmed">22066931</ArticleId></ArticleIdList></Reference><Reference><Citation>Hwang J.Y., Lee K.M., Kim Y.H., Shim H.M., Bae Y.K., Hwang J.H., Park H. Pregnancy Loss Following Coxsackievirus B3 Infection in Mice during Early Gestation Due to High Expression of Coxsackievirus-Adenovirus Receptor (CAR) in Uterus and Embryo. Exp. Anim. 2014;63:63–72. doi: 10.1538/expanim.63.63.</Citation><ArticleIdList><ArticleId IdType="doi">10.1538/expanim.63.63</ArticleId><ArticleId IdType="pmc">PMC4160930</ArticleId><ArticleId IdType="pubmed">24521864</ArticleId></ArticleIdList></Reference><Reference><Citation>Mata L., Urrutia J.J., Serrato G., Mohs E., Chin T.D.Y. Viral infections during pregnancy and in early life. Am. J. Clin. Nutr. 1977;30:1834–1842. doi: 10.1093/ajcn/30.11.1834.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ajcn/30.11.1834</ArticleId><ArticleId IdType="pubmed">920644</ArticleId></ArticleIdList></Reference><Reference><Citation>Morens D.M., Pallansch M.A., Moore M. Polioviruses and other enteroviruses. In: Belshe R.B., editor. Textbook of Human Virology. Mosby Year Book; St. Louis, MO, USA: 1991. pp. 427–497.</Citation></Reference><Reference><Citation>Tariq N., Kyriakopoulos C.  StatPearls. StatPearls Publishing; Treasure Island, FL, USA: 2024.  [(accessed on 10 July 2023)]. Group B Coxsackie Virus. Available online:  https://www.ncbi.nlm.nih.gov/books/NBK560783.</Citation><ArticleIdList><ArticleId IdType="pubmed">32809618</ArticleId></ArticleIdList></Reference><Reference><Citation>Selinka H.-C., Wolde A., Sauter M., Kandolf R., Klingel K. Virus-receptor interactions of coxsackie B viruses and their putative influence on cardiotropism. Med. Microbiol. Immunol. 2004;193:127–131. doi: 10.1007/s00430-003-0193-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00430-003-0193-y</ArticleId><ArticleId IdType="pubmed">12920584</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmidtke M., Selinka H.-C., Heim A., Jahn B., Tonew M., Kandolf R., Stelzner A., Zell R. Attachment of coxsackievirus B3 variants to various cell lines: mapping of phenotypic differences to capsid protein VP1. Virology. 2000;275:77–88. doi: 10.1006/viro.2000.0485.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/viro.2000.0485</ArticleId><ArticleId IdType="pubmed">11017789</ArticleId></ArticleIdList></Reference><Reference><Citation>Bergelson J.M., Cunningham J.A., Droguett G., Kurt-Jones E.A., Krithivas A., Hong J.S., Horwitz M.S., Crowell R.L., Finberg R.W. Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5. Science. 1997;275:1320–1323. doi: 10.1126/science.275.5304.1320.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.275.5304.1320</ArticleId><ArticleId IdType="pubmed">9036860</ArticleId></ArticleIdList></Reference><Reference><Citation>Tomko R.P., Xu R., Philipson L. HCAR and MCAR: The human and mouse cellular receptors for subgroup C adenoviruses and group B coxsackieviruses. Proc. Natl. Acad. Sci. USA. 1997;94:3352–3356. doi: 10.1073/pnas.94.7.3352.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.94.7.3352</ArticleId><ArticleId IdType="pmc">PMC20373</ArticleId><ArticleId IdType="pubmed">9096397</ArticleId></ArticleIdList></Reference><Reference><Citation>Shafren D.R., Bates R.C., Agrez M.V., Herd R.L., Burns G.F., Barry R.D. Coxsackieviruses B1, B3, and B5 use decay accelerating factor as a receptor for cell attachment. J. Virol. 1995;69:3873–3877. doi: 10.1128/jvi.69.6.3873-3877.1995.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.69.6.3873-3877.1995</ArticleId><ArticleId IdType="pmc">PMC189108</ArticleId><ArticleId IdType="pubmed">7538177</ArticleId></ArticleIdList></Reference><Reference><Citation>Asher D.R., Cerny A.M., Weiler S.R., Horner J.W., Keeler M.L., Neptune M.A., Finberg R.W. Coxsackievirus and adenovirus receptor is essential for cardiomyocyte development. Genesis. 2005;42:77–85.</Citation><ArticleIdList><ArticleId IdType="pubmed">15864812</ArticleId></ArticleIdList></Reference><Reference><Citation>Dorner A.A., Wegmann F., Butz S., Wolburg-Buchholz K., Wolburg H., Mack A., Nasdala I., August B., Westermann J., Rathjen F.G., et al. Coxsackievirus-adenovirus receptor (CAR) is essential for early embryonic cardiac development. J. Cell Sci. 2005;118:3509–3521. doi: 10.1242/jcs.02476.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.02476</ArticleId><ArticleId IdType="pubmed">16079292</ArticleId></ArticleIdList></Reference><Reference><Citation>Honda T., Saitoh H., Masuko M., Katagiri-Abe T., Tominaga K., Kozakai I., Kobayashi K., Kumanishi T., Watanabe Y.G., Odani S., et al. The coxsackievirus-adenovirus receptor protein as a cell adhesion molecule in the developing mouse brain. Mol. Brain Res. 2000;77:19–28. doi: 10.1016/s0169-328x(00)00036-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0169-328x(00)00036-x</ArticleId><ArticleId IdType="pubmed">10814828</ArticleId></ArticleIdList></Reference><Reference><Citation>Koi H., Zhang J., Makrigiannakis A., Getsios S., MacCalman C.D., Kopf G.S., Strauss J.F., Parry S. Differential expression of the coxsackievirus and adenovirus receptor regulates adenovirus infection of the placenta. Biol. Reprod. 2001;64:1001–1009. doi: 10.1095/biolreprod64.3.1001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1095/biolreprod64.3.1001</ArticleId><ArticleId IdType="pubmed">11207218</ArticleId></ArticleIdList></Reference><Reference><Citation>MacCalman C.D., Furth E.E., Omigbodun A., Kozarsky K.F., Coutifaris C., Strauss I.I.I.J.F. Transduction of human trophoblast cells by recombinant adenoviruses is differentiation dependent. Biol. Reprod. 1996;54:682–691.</Citation><ArticleIdList><ArticleId IdType="pubmed">8835392</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith S., Baker P.N., Symonds E. Placental apoptosis in normal human pregnancy. Am. J. Obstet. Gynecol. 1997;177:57–65. doi: 10.1016/s0002-9378(97)70438-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0002-9378(97)70438-1</ArticleId><ArticleId IdType="pubmed">9240583</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith S.C., Baker P.N., Symonds E. Increased placental apoptosis in intrauterine growth restriction. Am. J. Obstet. Gynecol. 1997;177:1395–1401. doi: 10.1016/s0002-9378(97)70081-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0002-9378(97)70081-4</ArticleId><ArticleId IdType="pubmed">9423741</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenberg M., Abramson H., Cooper H.M., Solomon H.E. The relation between recent injections and paralytic poliomyelitis in children. Am. J. Public Health Nations Health. 1952;42:142–152. doi: 10.2105/ajph.42.2.142.</Citation><ArticleIdList><ArticleId IdType="doi">10.2105/ajph.42.2.142</ArticleId><ArticleId IdType="pmc">PMC1525737</ArticleId><ArticleId IdType="pubmed">14903227</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren R., Racaniello V.R. Poliovirus Spreads from Muscle to the Central Nervous System by Neural Pathways. J. Infect. Dis. 1992;166:747–752. doi: 10.1093/infdis/166.4.747.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/166.4.747</ArticleId><ArticleId IdType="pubmed">1326581</ArticleId></ArticleIdList></Reference><Reference><Citation>Muir P., van Loon A. Enterovirus infections of the central nervous system. Intervirology. 1997;40:153–166. doi: 10.1159/000150542.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000150542</ArticleId><ArticleId IdType="pubmed">9450232</ArticleId></ArticleIdList></Reference><Reference><Citation>Berger J.R., Chumley W., Pittman T., Given C., Nuovo G. Persistent Coxsackie B encephalitis: Report of a case and review of the literature. J. Neurovirol. 2006;12:511–516.</Citation><ArticleIdList><ArticleId IdType="pubmed">17162666</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaplan M.H., Klein S.W., McPhee J., Harper R.G. Group B coxsackievirus infections in infants younger than three months of age: A serious childhood illness. Clin. Infect. Dis. 1983;5:1019–1032. doi: 10.1093/clinids/5.6.1019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/clinids/5.6.1019</ArticleId><ArticleId IdType="pubmed">6318288</ArticleId></ArticleIdList></Reference><Reference><Citation>Moore M., Kaplan M.H., McPhee J., Bregman D.J., Klein S.W. Epidemiologic, clinical, and laboratory features of Coxsackie B1-B5 infections in the United States, 1970–1979. Public Health Rep. 1984;99:515–522.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1424625</ArticleId><ArticleId IdType="pubmed">6091168</ArticleId></ArticleIdList></Reference><Reference><Citation>Romero J.R. Pediatric group B coxsackievirus infections. In: Tracy S., Oberste M.S., Drescher K.M., editors. Group B Coxsackieviruses. Volume 323. Springer; Berlin/Heidelberg, Germany: 2008. pp. 223–239. Current Topics in Microbiology and Immunology.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-3-540-75546-3_10</ArticleId></ArticleIdList></Reference><Reference><Citation>Bryant P.A., Tingay D., Dargaville P.A., Starr M., Curtis N. Neonatal coxsackie B virus infection—A treatable disease? Eur. J. Pediatr. 2004;163:223–228.</Citation><ArticleIdList><ArticleId IdType="pubmed">14986123</ArticleId></ArticleIdList></Reference><Reference><Citation>Theodoridou M., Kakourou T., Laina I., Mostrou G., Tsakris A. Vesiculopapular rash as a single presentation in intrauterine cox-sackie virus infection. Eur. J. Pediatr. 2002;161:412–413.</Citation><ArticleIdList><ArticleId IdType="pubmed">12174826</ArticleId></ArticleIdList></Reference><Reference><Citation>Callen J., Paes B.A. A case report of a premature infant with coxsackie B1 meningitis. Adv. Neonatal Care. 2007;7:238–247. doi: 10.1097/01.anc.0000296631.80926.8d.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.anc.0000296631.80926.8d</ArticleId><ArticleId IdType="pubmed">18049150</ArticleId></ArticleIdList></Reference><Reference><Citation>Schneider C., Menticoglou S., Herath J., Del Bigio M.R., Hunt J.C. Antenatal and postnatal diagnosis of coxsackie b4 infection: Case series. Am. J. Perinatol. Rep. 2011;2:1–6. doi: 10.1055/s-0031-1296027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0031-1296027</ArticleId><ArticleId IdType="pmc">PMC3653513</ArticleId><ArticleId IdType="pubmed">23946895</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng L.L., Ng P.C., Chan P.K.-S., Wong H.L., Cheng F.W.T., Tang J.W.-T. Probable intrafamilial transmission of coxsackievirus b3 with vertical transmission, severe early-onset neonatal hepatitis, and prolonged viral RNA shedding. Pediatrics. 2006;118:e929–e933. doi: 10.1542/peds.2006-0554.</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2006-0554</ArticleId><ArticleId IdType="pubmed">16908622</ArticleId></ArticleIdList></Reference><Reference><Citation>Khediri Z., Vauloup-Fellous C., Benachi A., Ayoubi J.M., Mandelbrot L., Picone O. Adverse effects of maternal enterovirus infection on the pregnancy outcome: A prospective and retrospective pilot study. Virol. J. 2018;15:70.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5902830</ArticleId><ArticleId IdType="pubmed">29661198</ArticleId></ArticleIdList></Reference><Reference><Citation>Ornoy A., Tenenbaum A. Pregnancy outcome following infections by coxsackie, echo, measles, mumps, hepatitis, polio and encephalitis viruses. Reprod. Toxicol. 2006;21:446–457. doi: 10.1016/j.reprotox.2005.12.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.reprotox.2005.12.007</ArticleId><ArticleId IdType="pubmed">16480851</ArticleId></ArticleIdList></Reference><Reference><Citation>Samuelson A., Skoog E., Forsgren M. Aspects on the serodiagnosis of enterovirus infections by ELISA. Serodiagn. Immunother. Infect. Dis. 1990;4:395–406. doi: 10.1016/0888-0786(90)90030-r.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0888-0786(90)90030-r</ArticleId></ArticleIdList></Reference><Reference><Citation>Bendig J.W., Franklin O.M., Hebden A.K., Backhouse P.J., Clewley J.P., Goldman A.P., Piggott N. Coxsackievirus B3 sequences in the blood of a neonate with congenital myocarditis, plus serological evidence of maternal infection. J. Med. Virol. 2003;70:606–609. doi: 10.1002/jmv.10437.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.10437</ArticleId><ArticleId IdType="pubmed">12794724</ArticleId></ArticleIdList></Reference><Reference><Citation>Ouellet A., Sherlock R., Toye B., Fung K.F.K. Antenatal diagnosis of intrauterine infection with coxsackievirus B3 associated with live birth. Infect. Dis. Obstet. Gynecol. 2000;12:23–26. doi: 10.1080/1064744042000210357.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/1064744042000210357</ArticleId><ArticleId IdType="pmc">PMC1784589</ArticleId><ArticleId IdType="pubmed">15460192</ArticleId></ArticleIdList></Reference><Reference><Citation>Strong B., Young S. Intrauterine coxsackie virus, group B type 1, infection: Viral cultivation from amniotic fluid in the third trimester. Am. J. Perinatol. 1995;12:78–79. doi: 10.1055/s-2007-994407.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-2007-994407</ArticleId><ArticleId IdType="pubmed">7779200</ArticleId></ArticleIdList></Reference><Reference><Citation>Dommergues M., Petitjean J., Aubry M., Delezoide A., Narcy F., Fallet-Bianco C., Freymuth F., Dumez Y., Lebon P. Fetal enteroviral infection with cerebral ventriculomegaly and cardiomyopathy. Fetal Diagn. Ther. 1994;9:77–78. doi: 10.1159/000263911.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000263911</ArticleId><ArticleId IdType="pubmed">8185842</ArticleId></ArticleIdList></Reference><Reference><Citation>Krivega M., Geens M., Van de Velde H. CAR expression in human embryos and hESC illustrates its role in pluripotency and tight junctions. Reproduction. 2014;148:531–544. doi: 10.1530/rep-14-0253.</Citation><ArticleIdList><ArticleId IdType="doi">10.1530/rep-14-0253</ArticleId><ArticleId IdType="pubmed">25118298</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonnin A., Tassin M., Vauloup-Fellous C., Letamendia E., Stos B., Bonnet D., Gajdos V., Mabille M., Benachi A. Case of a healthy infant born following antenatal enterovirus myocarditis and hydrops. J. Clin. Virol. 2014;61:459–462. doi: 10.1016/j.jcv.2014.08.028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2014.08.028</ArticleId><ArticleId IdType="pubmed">25242311</ArticleId></ArticleIdList></Reference><Reference><Citation>Batcup G., Holt P., Hambling M., Gerlis L., Glass M. Placental and fetal pathology in Coxsackie virus A9 infection: A case report. Histopathology. 1985;9:1227–1235. doi: 10.1111/j.1365-2559.1985.tb02802.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2559.1985.tb02802.x</ArticleId><ArticleId IdType="pubmed">4085986</ArticleId></ArticleIdList></Reference><Reference><Citation>Freund M.W., Kleinveld G., Krediet T.G., van Loon A.M., Verboon-Maciolek M.A. Prognosis for neonates with enterovirus myo-carditis. Arch. Dis. Child-Fetal Neonatal Ed. 2010;95:F206–F212.</Citation><ArticleIdList><ArticleId IdType="pubmed">20444813</ArticleId></ArticleIdList></Reference><Reference><Citation>Erickson L.S., Hoyle G., Abramson J., Hester L.C., Shetty A.K. Coxsackie B1 infection associated with ventriculitis. Pediatr. Infect. Dis. J. 2003;22:750–751. doi: 10.1097/01.inf.0000078162.99789.ca.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.inf.0000078162.99789.ca</ArticleId><ArticleId IdType="pubmed">12938678</ArticleId></ArticleIdList></Reference><Reference><Citation>Bauer S., Gottesman G., Sirota L., Litmanovitz I., Ashkenazi S., Levi I. Severe Coxsackie virus B infection in preterm newborns treated with pleconaril. Eur. J. Pediatr. 2002;161:491–493. doi: 10.1007/s00431-002-0929-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00431-002-0929-5</ArticleId><ArticleId IdType="pubmed">12200608</ArticleId></ArticleIdList></Reference><Reference><Citation>Dahlquist G., Frisk G., Ivarsson S., Svanberg L., Forsgren M., Diderholm H. Indications that maternal coxsackie B virus infection during pregnancy is a risk factor for childhood-onset IDDM. Diabetologia. 1995;38:1371–1373.</Citation><ArticleIdList><ArticleId IdType="pubmed">8582549</ArticleId></ArticleIdList></Reference><Reference><Citation>Tracy S., Gauntt C. Current Topics in Microbiology and Immunology: Group B Coxsackievirus Virulence. Volume 323. Springer; Berlin/Heidelberg, Germany: 2008. pp. 49–63.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-3-540-75546-3</ArticleId><ArticleId IdType="pubmed">18357765</ArticleId></ArticleIdList></Reference><Reference><Citation>Hyöty H., Hiltunen M., Knip M., Laakkonen M., Vähäsalo P., Karjalainen J., Åkerblom H.K. A prospective study of the role of coxsackie B and other enterovirus infections in the pathogenesis of IDDM. Diabetes. 1995;44:652–658.</Citation><ArticleIdList><ArticleId IdType="pubmed">7789630</ArticleId></ArticleIdList></Reference><Reference><Citation>Dahlquist G.G., Ivarsson S., Lindberg B., Forsgren M. Maternal enteroviral infection during pregnancy as a risk factor for childhood IDDM: A population-based case-control study. Diabetes. 1995;44:408–413.</Citation><ArticleIdList><ArticleId IdType="pubmed">7698508</ArticleId></ArticleIdList></Reference><Reference><Citation>Füchtenbusch M., Irnstetter A., Jäger G., Ziegler A.-G. No evidence for an association of coxsackie virus infections during pregnancy and early childhood with development of islet autoantibodies in offspring of mothers or fathers with type 1 diabetes. J. Autoimmun. 2001;17:333–340. doi: 10.1006/jaut.2001.0550.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/jaut.2001.0550</ArticleId><ArticleId IdType="pubmed">11771958</ArticleId></ArticleIdList></Reference><Reference><Citation>Euscher E., Davis J., Holzman I., Nuovo G.J. Coxsackie virus infection of the placenta associated with neurodevelopmental delays in the newborn. Obstet. Gynecol. 2001;98:1019–1026.</Citation><ArticleIdList><ArticleId IdType="pubmed">11755547</ArticleId></ArticleIdList></Reference><Reference><Citation>Watson W.J., Awadallah S., Jaqua M.J. Intrauterine infection with coxsackievirus: Is it a cause of congenital cardiac malformations? Infect. Dis. Obstet. Gynecol. 1995;3:79–81.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2364419</ArticleId><ArticleId IdType="pubmed">18476025</ArticleId></ArticleIdList></Reference><Reference><Citation>Gauntt C.J., Gudvangen R.J., Brans Y.W., Marlin A.E. Coxsackievirus group B antibodies in the ventricular fluid of infants with severe anatomic defects in the central nervous sys-tem. Pediatrics. 1985;76:64–68. doi: 10.1542/peds.76.1.64.</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.76.1.64</ArticleId><ArticleId IdType="pubmed">2989763</ArticleId></ArticleIdList></Reference><Reference><Citation>Abzug M.J. Prognosis for neonates with enterovirus hepatitis and coagulopathy. Pediatr. Infect. Dis. J. 2001;20:758–763. doi: 10.1097/00006454-200108000-00008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00006454-200108000-00008</ArticleId><ArticleId IdType="pubmed">11734737</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma V., Goessling L.S., Brar A.K., Eghtesady P. In utero infection with coxsackievirus-B is associated with congenital pulmonary atresia. medRxiv. 2020 doi: 10.1101/2020.04.18.20070813.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.04.18.20070813</ArticleId></ArticleIdList></Reference><Reference><Citation>Satosar A., Ramirez N.C., Bartholomew D., Davis J., Nuovo G.J. Histologic correlates of viral and bacterial infection of the placenta associated with severe morbidity and mortality in the newborn. Hum. Pathol. 2004;35:536–545. doi: 10.1016/j.humpath.2004.01.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.humpath.2004.01.015</ArticleId><ArticleId IdType="pubmed">15138926</ArticleId></ArticleIdList></Reference><Reference><Citation>Axelsson C., Bondestam K., Frisk G., Bergström S., Diderholm H. Coxsackie B virus infections in women with miscarriage. J. Med. Virol. 1993;39:282–285. doi: 10.1002/jmv.1890390405.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.1890390405</ArticleId><ArticleId IdType="pubmed">8388026</ArticleId></ArticleIdList></Reference><Reference><Citation>Abzug M.J., Keyserling H.L., Lee M.L., Levin M.J., Rotbart H.A. Neonatal enterovirus infection: Virology, serology, and effects of intravenous immune globulin. Clin. Infect. Dis. 1995;20:1201–1206. doi: 10.1093/clinids/20.5.1201.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/clinids/20.5.1201</ArticleId><ArticleId IdType="pubmed">7620000</ArticleId></ArticleIdList></Reference><Reference><Citation>Rotbart H.A., Webster A.D., Pleconaril Treatment Registry Group Treatment of potentially life-threatening enterovirus infections with pleconaril. Clin. Infect. Dis. 2001;32:228–235. doi: 10.1086/318452.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/318452</ArticleId><ArticleId IdType="pubmed">11170912</ArticleId></ArticleIdList></Reference><Reference><Citation>Hyöty H., Leon F., Knip M. Developing a vaccine for type 1 diabetes by targeting coxsackievirus B. Expert Rev. Vaccines. 2018;17:1071–1083. doi: 10.1080/14760584.2018.1548281.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14760584.2018.1548281</ArticleId><ArticleId IdType="pubmed">30449209</ArticleId></ArticleIdList></Reference><Reference><Citation>Jubelt B., Lipton H.L. Handbook of Clinical Neurology. Volume 123. Elsevier; Amsterdam, The Netherlands: 2014. Enterovirus/Picornavirus infections; pp. 379–416.</Citation><ArticleIdList><ArticleId IdType="pubmed">25015496</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>